Immunocompromised

Screening newborns for severe combined immunodeficiency saves lives, study finds

In a study, widespread screening and early treatment of newborn babies with severe combined immunodeficiency boosted their five-year survival rate from 73% to 87%.

June 21, 2023

IsoPlexis joins MediMergent, CCBD for COVID-19 study

The large multisite study will focus on the functionality of immune cells and their role in prevention of breakthrough COVID-19 infections in immunocompromised patients following administration of AstraZeneca's AZD7442 IM or IV antibody combination.

September 5, 2022

CoVac-1 vaccine shows promise for immunocompromised patients

Walz's team used their expertise with cancer therapeutics to develop a vaccine that induces T cells in immunocompromised patients who do not produce an adequate immune response to other vaccines.

May 1, 2022

Karius raises $165M for infectious disease blood test

The Redwood City, CA-based company markets the Karius test, a next-generation sequencing and artificial intelligence-powered option designed to screen blood for 1,000 pathogens, including bacteria, fungi, DNA viruses, and parasites. The test is being positioned for a range of applications, including complicated pneumonia, infections in immunocompromised patients, and endocarditis.

February 24, 2020

Roche launches adenovirus PCR test in Europe

Transplant patients are immunocompromised and at risk for developing infections, including from adenoviruses. Adenoviruses can lead to a range of conditions -- such as conjunctivitis, gastroenteritis, hepatitis, and pneumonia -- that cause complications and organ rejection in transplant patients.

January 14, 2020